Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of ciprofol for laryngeal mask insertion in children with different sufentanil doses
ChiCTR2500099371Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Mar 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol (3 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoint: ED90 of ciprofol required for smooth laryngeal mask airway insertion. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2500099371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099371.